More broadly, our findings suggest that GLP1R agonists could have applications in disorders of dysregulated reward signalling, including substance-use disorders
Because these toxins negatively affect kidney function, they are implicated in kidney damage in CKD (10-14)
Moreover, a large-scale randomized controlled trial (RCTs) involving more than 17,000 individuals with obesity and cardiovascular disease demonstrated that semaglutide reduced the risk of cardiovascular death, myocardial infarction (MI), and stroke compared to the placebo 9
Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity
Common drug side effects can include diarrhea and vomiting that can make anyone less inclined to be in the mood for sex
The genetics of asthma: are the glutathione S-transferases serious players